Glaucoma
Presenter: Dr Manyando Musiwa
(MBCHB, MPH, Mmed Ophth, FCO(ECSA)
Date: 14th November, 2025
INTRODUCTION
• A group of diseases characterized by decreased peripheral vision,
visual field defects with or without increased IOP
• Second leading cause of blindness globally
• 80 million people globally have Glaucoma (WHO, 2024)
• In Zambia 4.2 % of adult population with glaucoma and 8.6% with
Juvenile Glaucoma( Muma et al., 2025)
RISK FACTORS
• have high eye pressure
• are farsighted or near sighted
• have had an eye injury
• use long-term steroid medications
• have corneas that are thin in the center
• have thinning of the optic nerve
• have diabetes, migraines, high blood pressure poor blood circulation or
other health problems affecting the whole body
• are over age 40
• have family members with glaucoma
• are of African, Hispanic, or Asian heritage
SYMPTOMS
EXAMINATION
INVESTIGATIONS
Treatment
EFFECT ON PILOTING
Decreased peripheral vision impairs:
• Situational analysis
• Spartial orientation
• Risk of disorientation
• Altitude effects
REFERENCES
• "Angle-Closure Glaucoma - American Academy of
Ophthalmology". www.aao.org.
• Friedman NJ, Kaiser PK, Pineda II R (2014). The Massachusetts Eye and Ear
Infirmary Illustrated Manual of Ophthalmology E-Book. Elsevier Health
Sciences. p. 234. ISBN 978-0-323-22527-4.
• Kim KE, Park KH (2016). "Update on the Prevalence, Etiology, Diagnosis,
and Monitoring of Normal-Tension Glaucoma". Asia Pac J Ophthalmol
(Phila). 5 (1): 23–
31. doi:10.1097/APO.0000000000000177. PMID 26886116., (review) (open
access).
• Gordon MO, Kass MA (2018). "What We Have Learned From the Ocular
Hypertension Treatment Study". Am J Ophthalmol. 189: xxiv–
xxvii. doi:10.1016/j.ajo.2018.02.016. PMC 5915899. PMID 29501371.